News for Healthier Living

Pancreatic Cancer Discovery Advances Toward First-of-Its-Kind Clinical Trial

Sylvester researchers identified IL1RAP as a key driver of pancreatic cancer treatment resistance. Backed by a V Foundation grant, the findings are advancing into a first-of-its-kind clinical trial combining IL1RAP-targeted therapy with chemoimmunotherapy before surgery.

June 23, 2026


July 3 2026

July 2 2026

July 1 2026

June 30 2026

June 29 2026

June 26 2026

June 25 2026

June 24 2026

June 23 2026

June 22 2026

June 21 2026

June 19 2026